These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 19429089

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain.
    Vilpoux C, Leroux-Nicollet I, Naudon L, Raisman-Vozari R, Costentin J.
    Neuropharmacology; 2000 Apr 03; 39(6):1075-82. PubMed ID: 10727718
    [Abstract] [Full Text] [Related]

  • 3. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C, Reither H, Hornykiewicz O.
    Eur J Pharmacol; 2015 May 15; 755():119-26. PubMed ID: 25771452
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.
    Rau KS, Birdsall E, Volz TJ, Riordan JA, Baucum AJ, Adair BP, Bitter R, Gibb JW, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2006 Aug 15; 318(2):676-82. PubMed ID: 16687477
    [Abstract] [Full Text] [Related]

  • 6. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
    Nickell JR, Krishnamurthy S, Norrholm S, Deaciuc G, Siripurapu KB, Zheng G, Crooks PA, Dwoskin LP.
    J Pharmacol Exp Ther; 2010 Feb 15; 332(2):612-21. PubMed ID: 19855096
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
    Lizarraga LE, Cholanians AB, Phan AV, Herndon JM, Lau SS, Monks TJ.
    Toxicol Sci; 2015 Jan 15; 143(1):209-19. PubMed ID: 25370842
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.
    Maier J, Mayer FP, Luethi D, Holy M, Jäntsch K, Reither H, Hirtler L, Hoener MC, Liechti ME, Pifl C, Brandt SD, Sitte HH.
    Neuropharmacology; 2018 Aug 15; 138():282-291. PubMed ID: 29908239
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Maurel S, De Vry J, Schreiber R.
    Alcohol; 1999 Apr 15; 17(3):195-201. PubMed ID: 10231167
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P.
    Clin Pharmacokinet; 1996 Dec 15; 31(6):444-69. PubMed ID: 8968657
    [Abstract] [Full Text] [Related]

  • 16. The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.
    Beckmann JS, Siripurapu KB, Nickell JR, Horton DB, Denehy ED, Vartak A, Crooks PA, Dwoskin LP, Bardo MT.
    J Pharmacol Exp Ther; 2010 Dec 15; 335(3):841-51. PubMed ID: 20805303
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis.
    Guillot TS, Shepherd KR, Richardson JR, Wang MZ, Li Y, Emson PC, Miller GW.
    J Neurochem; 2008 Sep 15; 106(5):2205-17. PubMed ID: 18643795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.